KBLB

$0.08+0.12%visit website

Kraig Biocraft Laboratories, Inc.

Market Cap

$92M

Live price × SEC shares (Aug 13, 2026)

Sector

Materials

Industry

Chemicals

Beta (raw)

1.72

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

N/M

TTM to Jun 2026 · negative equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Research & development	9	69	67	64	209
Total operating expenses	1,434	723	826	703	3,685
Operating income	(1,434)	(723)	(826)	(703)	(3,685)
Interest expense	144	144	148	151	588
Pretax income	(1,510)	(788)	(943)	(910)	(4,149)
Net income	(1,510)	(788)	(943)	(910)	(4,149)
EPS (basic) ($)	0.00		0.00	0.00	0.00
EPS (diluted) ($)	0.00		0.00	0.00	0.00
Weighted avg. shares (basic)	1,068,264		1,090,869	1,110,343
Weighted avg. shares (diluted)	1,068,264		1,090,869	1,110,343

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 13, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

1 filing in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Feb 18, 2026 accepted 11:17 AM ET	8.01Other events	Document SEC ↗
Jan 21, 2025 accepted 5:14 PM ET	1.01Material agreement3.02Unregistered equity sale7.01Reg FD disclosure	Document SEC ↗